Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...

AirBaltic continues to work on plans for an initial public offering (IPO), which is now set to take place in the spring of ...

Indobell Insulation’s IPO, worth ₹10.14 crore, was fully subscribed on its first day. The offering is priced at ₹46 per share ...

Spanish travel technology firm HBX Group is considering announcing plans for an initial public offering as early as next week ...

A biopharmaceutical company and its executives misled investors ahead of its 2024 initial public offering about a key ...

Molida Holding Group filed for an initial public offering with the Securities and Exchange Commission on Tuesday. The blank-check company would offer 12 million ordinary shares, expecting to sell each ...

The issue, which has a price band set between ₹275-290 per share for its initial offering, is set to open for public ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...

The initial public offering (IPO) of Quadrant Future Tek Limited has officially opened today, January 7, 2025, to positive ...

Standard Glass Lining Technology, Quadrant Future Tek, and Capital Infra Trust. Each presents unique opportunities and risks, ...